PIK3CD and breast carcinoma: For example, PI3K signaling is overactivated in breast cancer, inhibition of PI3K reduces the incidence of triple-negative and estrogen receptor-positive breast cancer, and in advanced and metastatic breast cancer, PI3KCA mutations may lead to chemoresistance and poor prognosis [35, 36].